Skip to content
Home/Companies/Healthcare/Ad Scientiam

Ad Scientiam

Healthcare·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Ad Scientiam?

Ad Scientiam is currently owned by TechLife Capital through TechLife Capital II (2024 vintage), since 2025.

Hand-verified · updated 2026-06-10

TechLife Capital
Investor
TechLife Capital
TechLife Capital II · 2024 · Growth

Key facts

HQFrance
SectorHealthcare
StatusActive

More from TechLife Capital II

Other portfolio companies in the same fund.

Studia
Active
SoftwareFrance· 2026
Créative
Créative
Active
TMTFrance· 2025
Evolutis
Evolutis
Active
HealthcareFrance· 2023
Quinten Health
Quinten Health
Active
HealthcareFrance· 2022
Flash Therapeutics
Active
HealthcareFrance· 2021
MyData Trust
MyData Trust
Active
TMTFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Ad Scientiam

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ad Scientiam.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue